Vittoria Vardanega

Health and data journalist. I cover a wide range of healthcare topics, from cutting-edge therapies to global health. My stories are often data-driven, and I strive to make complex issues clear and accessible. Before becoming a full-time journalist, I worked in communication, research, and data analysis for the UN and EU. In the private sector, I developed health economics models to inform policy and investment decisions. Originally from Italy, I am now based in Zurich.

A campaign to allow a limited "Right to Be Forgotten" is trying to provide better financial security for thousands of former cancer patients.

Health systems

Cured but uninsurable: the hidden financial burden of surviving cancer in Switzerland

This content was published on Apr 15, 2026 More people are surviving cancer than ever before. But in Switzerland a historical diagnosis can follow former patients for years.

Health systems

When sperm crosses borders, national safeguards fall short

This content was published on Feb 13, 2026 The sperm of a Danish donor carried a cancer-causing genetic mutation that led to the deaths of children. Switzerland’s strict regulations make scenarios of this scale unlikely.

Microscope screen of a colon cancer cell.

New treatments

More young adults are getting bowel cancer. Is Switzerland screening too late?

This content was published on Dec 10, 2025 Colorectal cancer rates are growing among the under-50. When is the right time to scan?

Female patient lying in hospital bed (KEYSTONE/PHOTOALTO "S/Michele Constantini)

Medicine access

Under-50s cancer patients face system unprepared for them

This content was published on Nov 17, 2025 Countries, including Switzerland, are struggling to deal with the challenges posed by rising cancer rates among people under 50.

Medicine access

Dealing with vaccine hesitancy in the age of misinformation – lessons from Switzerland

This content was published on Jul 12, 2025 In Switzerland, complementary and alternative medicine is key to addressing vaccine hesitancy.

A pharmacist with a customer in France offering a generic drug.

Pharma supply chains

How US tariffs could disrupt the generic drugs supply chain

This content was published on Jul 1, 2025 US tariffs on generics could raise drug prices and accentuate shortages. That's not what US President Donald Trump had in mind.

MMR vaccine. Syringe and vial on a counter. This combined vaccine protects infants from three viral diseases: measles, mumps and rubella.

Medicine access

One paper, 20 years of damage

This content was published on May 30, 2025 Nearly 30 years ago an academic paper wrongly linked autism to a measles vaccine. The impacts are still being felt today.

Patient safety

Global concern over measles is rising. Should Switzerland worry?

This content was published on May 30, 2025 Measles is making a global comeback. In Switzerland, a crisis is unlikely – but authorities warn a strong vaccination rate remains crucial.

Vittoria Vardanega

More

Cured but uninsurable: the hidden financial burden of surviving cancer in Switzerland

More

When sperm crosses borders, national safeguards fall short

More

More young adults are getting bowel cancer. Is Switzerland screening too late?

More

Under-50s cancer patients face system unprepared for them

More

Dealing with vaccine hesitancy in the age of misinformation – lessons from Switzerland

More

How US tariffs could disrupt the generic drugs supply chain

More

One paper, 20 years of damage

More

Global concern over measles is rising. Should Switzerland worry?

Popular Stories

Most Discussed